News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva Pharmaceutical Industries Limited (TEVA) Provides Update on Generic Ortho Tri-Cyclen(R) Lo


7/7/2009 8:53:25 AM

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that further to its press release dated July 1, 2009, Teva and Ortho McNeil Janssen have agreed to cease shipments of generic versions of Ortho Tri-Cyclen® Lo, pending a preliminary injunction hearing in the related patent infringement case which is scheduled to begin on July 15, 2009 at 9:30 a.m.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES